130 related articles for article (PubMed ID: 7379454)
21. Motility of neutrophils and monocytes in Crohn's disease and ulcerative colitis.
Rhodes JM; Jewell DP
Gut; 1983 Jan; 24(1):73-7. PubMed ID: 6848434
[TBL] [Abstract][Full Text] [Related]
22. Increased group II phospholipase A2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis.
Minami T; Tojo H; Shinomura Y; Matsuzawa Y; Okamoto M
Gut; 1994 Nov; 35(11):1593-8. PubMed ID: 7828979
[TBL] [Abstract][Full Text] [Related]
23. Prolyl hydroxylase activity in serum and rectal mucosa in inflammatory bowel disease.
Farthing MF; Dick AP; Heslop G; Levene CI
Gut; 1978 Aug; 19(8):743-7. PubMed ID: 210089
[TBL] [Abstract][Full Text] [Related]
24. Serum angiotensin converting enzyme activity in Crohn's disease and ulcerative colitis.
Letizia C; D'Ambrosio C; Agostini D; Corsi A; Boirivant M; Pallone F; Scavo D
Ital J Gastroenterol; 1993 Jan; 25(1):23-5. PubMed ID: 8381313
[TBL] [Abstract][Full Text] [Related]
25. Serum lysozyme activity in inflammatory bowel disease.
Levy N; Gibson RG; Mihas AA; Hirschowitz BI
South Med J; 1978 Sep; 71(9):1109-11. PubMed ID: 684504
[TBL] [Abstract][Full Text] [Related]
26. Abnormalities of jejunal mucosal enzymes in ulcerative colitis and Crohn's disease.
Arvanitakis C
Digestion; 1979; 19(4):259-66. PubMed ID: 478207
[TBL] [Abstract][Full Text] [Related]
27. Matrix metalloproteinases (MMP-3 and MMP-9) implication in the pathogenesis of inflammatory bowel disease (IBD).
Siloşi I; Boldeanu MV; Mogoantă SŞ; Ghiluşi M; Cojocaru M; Biciuşcă V; Cojocaru IM; Avrămescu CS; Gheonea DI; Siloşi CA; Turculeanu A
Rom J Morphol Embryol; 2014; 55(4):1317-24. PubMed ID: 25611261
[TBL] [Abstract][Full Text] [Related]
28. Immunohistochemical identification of lysozyme in intestinal lesions in ulcerative colitis and Crohn's disease.
Klockars M; Reitamo S; Reitamo JJ; Möller C
Gut; 1977 May; 18(5):377-81. PubMed ID: 326636
[TBL] [Abstract][Full Text] [Related]
29. Subcellular fractionation of rectal biopsy homogenates from patients with inflammatory bowel disease.
O'Morain C; Smethurst P; Levi J; Peters TJ
Scand J Gastroenterol; 1985 Mar; 20(2):209-14. PubMed ID: 3992179
[TBL] [Abstract][Full Text] [Related]
30. Plasma lysosomal enzyme activity in acute myocardial infarction.
Welman E; Selwyn AP; Peters TJ; Colbeck JF; Fox KM
Cardiovasc Res; 1978 Feb; 12(2):99-105. PubMed ID: 647716
[TBL] [Abstract][Full Text] [Related]
31. Peripheral blood monocyte cytokine production and acute phase response in inflammatory bowel disease.
Mazlam MZ; Hodgson HJ
Gut; 1992 Jun; 33(6):773-8. PubMed ID: 1624158
[TBL] [Abstract][Full Text] [Related]
32. Immunoglobulin G subclass distribution of anti-endothelial cell antibodies (AECA) in patients with ulcerative colitis or Crohn's disease.
Aldebert D; Masy E; Reumaux D; Lion G; Colombel JF; Duthilleul P
Dig Dis Sci; 1997 Nov; 42(11):2350-5. PubMed ID: 9398816
[TBL] [Abstract][Full Text] [Related]
33. Occupational exposure to benzene, toluene and xylene and the lymphocyte lysosomal N-acetyl-beta-D-glucosaminidase.
Moszczyński P; Lisiewicz J
Ind Health; 1985; 23(1):47-51. PubMed ID: 3997566
[No Abstract] [Full Text] [Related]
34. Circulating human leucocyte elastase in patients with inflammatory bowel disease.
Adeyemi EO; Neumann S; Chadwick VS; Hodgson HJ; Pepys MB
Gut; 1985 Dec; 26(12):1306-11. PubMed ID: 3853525
[TBL] [Abstract][Full Text] [Related]
35. Increased mucosal matrix metalloproteinase-1, -2, -3 and -9 activity in patients with inflammatory bowel disease and the relation with Crohn's disease phenotype.
Meijer MJ; Mieremet-Ooms MA; van der Zon AM; van Duijn W; van Hogezand RA; Sier CF; Hommes DW; Lamers CB; Verspaget HW
Dig Liver Dis; 2007 Aug; 39(8):733-9. PubMed ID: 17602907
[TBL] [Abstract][Full Text] [Related]
36. Biochemical analysis of enzymic markers of inflammation in rectal biopsies from patients with ulcerative colitis and Crohn's disease.
O'Morain C; Smethurst P; Levi AJ; Peters TJ
J Clin Pathol; 1983 Nov; 36(11):1312-6. PubMed ID: 6313772
[TBL] [Abstract][Full Text] [Related]
37. Serum nitrate levels in ulcerative colitis and Crohn's disease.
Oudkerk Pool M; Bouma G; Visser JJ; Kolkman JJ; Tran DD; Meuwissen SG; Peña AS
Scand J Gastroenterol; 1995 Aug; 30(8):784-8. PubMed ID: 7481547
[TBL] [Abstract][Full Text] [Related]
38. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
[TBL] [Abstract][Full Text] [Related]
39. Monocytes in inflammatory bowel disease: phagocytosis and intracellular killing.
Mee AS; Szawatakowski M; Jewell DP
J Clin Pathol; 1980 Oct; 33(10):921-5. PubMed ID: 7430357
[TBL] [Abstract][Full Text] [Related]
40. Serum lysozyme in inflammatory bowel and coeliac disease.
Mallas E; Terry JM; Asquith P; Cooke WT
J Clin Pathol; 1976 Jul; 29(7):598-600. PubMed ID: 977770
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
